CD274 and hepatocellular carcinoma: In conclusion, we showed the potential usefulness of pretreatment cfDNA/ctDNA profiling for predicting the clinical outcome in u-HCC patients treated with anti-PD-L1 and anti-VEGF combination immunotherapy.